Literature DB >> 6146378

Somatostatin and ranitidine in the control of iatrogenic haemorrhage of the upper gastrointestinal tract.

F Coraggio, P Scarpato, M Spina, S Lombardi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6146378      PMCID： PMC1442323          DOI： 10.1136/bmj.289.6439.224

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  4 in total

1.  Cytoprotection - organoprotection by somatostatin: gastric and hepatic lesions.

Authors:  S Szabo; K H Usadel
Journal:  Experientia       Date:  1982-02-15

2.  Somatostatin and cimetidine in peptic-ulcer haemorrhage. A randomised controlled trial.

Authors:  L Kayasseh; K Gyr; U Keller; G A Stalder; M Wall
Journal:  Lancet       Date:  1980-04-19       Impact factor: 79.321

3.  Effect of somatostatin on splanchnic hemodynamics in patients with cirrhosis of the liver and in normal subjects.

Authors:  G E Sonnenberg; U Keller; A Perruchoud; D Burckhardt; K Gyr
Journal:  Gastroenterology       Date:  1981-03       Impact factor: 22.682

4.  Effect of growth hormone release-inhibiting hormone on gastric secretion, mucosal blood flow, and serum gastrin.

Authors:  S J Konturek; J Tasler; M Cieszkowski; D H Coy; A V Schally
Journal:  Gastroenterology       Date:  1976-05       Impact factor: 22.682
  4 in total
  13 in total

1.  Drug treatment for acute upper gastrointestinal bleeding.

Authors:  S A Jenkins; R Shields
Journal:  BMJ       Date:  1992-03-21

2.  Octreotide for gastrointestinal bleeding of obscure origin in an anticoagulated patient.

Authors:  Luke T Nordquist; Paul M Wallach
Journal:  Dig Dis Sci       Date:  2002-07       Impact factor: 3.199

Review 3.  Therapeutic potential of a long acting somatostatin analogue in gastrointestinal diseases.

Authors:  L J O'Donnell; M J Farthing
Journal:  Gut       Date:  1989-09       Impact factor: 23.059

Review 4.  Bleeding peptic ulcer--endoscopic and pharmacological management.

Authors:  S C Jones; A T Axon
Journal:  Postgrad Med J       Date:  1991-07       Impact factor: 2.401

Review 5.  Clinical uses of gut peptides.

Authors:  J Geoghegan; T N Pappas
Journal:  Ann Surg       Date:  1997-02       Impact factor: 12.969

6.  Pharmacokinetics of ranitidine in acute upper gastrointestinal haemorrhage.

Authors:  O Varoquaux; J M Trawale; J Doll; J Andrieu; S Grosbuis; M Pays; C Advenier
Journal:  Br J Clin Pharmacol       Date:  1985-12       Impact factor: 4.335

7.  In vitro enhancement of human platelet aggregation by somatostatin.

Authors:  P P Gazzaniga; G Di Macco; R La Mancusa; A Oddi; G Pappalardo; F M Pulcinelli; D Reggio
Journal:  Experientia       Date:  1988-10-15

8.  Inhibition of meal stimulated gastric acid secretion by an octapeptide somatostatin analogue SMS 201-995.

Authors:  J A Olsen; F B Loud; J Christiansen
Journal:  Gut       Date:  1987-04       Impact factor: 23.059

9.  Somatostatin inhibits gastric acid secretion after gastric mucosal prostaglandin synthesis inhibition by indomethacin in man.

Authors:  M H Mogard; V Maxwell; T Kovacs; G Van Deventer; J D Elashoff; T Yamada; G L Kauffman; J H Walsh
Journal:  Gut       Date:  1985-11       Impact factor: 23.059

Review 10.  Ranitidine. An updated review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in peptic ulcer disease and other allied diseases.

Authors:  S M Grant; H D Langtry; R N Brogden
Journal:  Drugs       Date:  1989-06       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.